The mRNA expression of those canonical ER-targeted genes including EFP, COX7RP and EBAG9 were induced after E2 treatment as expected in breast cancer cells, but did not change significantly after knockdown of CALML3 compared to the control (Additional file 2: Figure S5C). This evidence concerns the gene ESR1 and breast cancer.